Home / Stocks / CLOV

CLOV insider trading

CLOVER HEALTH INVESTMENTS, CORP. /DE — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$1.1M
Buys · last 90 days
0 · $0
Most recent buy
2025-08-14

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-01Toy Andrew
Chief Executive Officer
Sold313,476$5.32$1.7M
2025-08-14Loengard Anna U
Director
Bought26,500$2.59$69k
2025-08-08Garipalli Vivek
Director · 10% owner
Bought446,980$2.23$999k

Most active insider buyers

InsiderRoleBuysTotal bought
Garipalli VivekDirector · 10% owner1$999k
Loengard Anna UDirector1$69k

See CLOV on the chart

Every insider buy and sell for CLOV plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.